How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,428,183 results for

omega-3

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Preoperative use of omega-3 fatty acids or vitamin E

Preoperative use of omega-3 fatty acids or vitamin E Preoperative use of omega-3 fatty acids or vitamin E We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Preoperative use of omega-3 fatty acids or vitamin E Share: Reading time approx. 1 minute Both omega-3 fatty acids and vitamin E are common in food supplements. Omega-3 are polyunsaturated fatty (...) acids present in example given marine oils while vitamin E is a fat soluble antioxidant. Question Can food supplements containing omega-3 fatty acids or vitamin E increase bleeding risk and should therefore be avoided during a period before a surgical intervention? Identified literature 1. Xin W, Wei W, Lin Z, Zhang X, Yang H, Zhang T, et al. Fish oil and atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials. PloS one. 2013;8(9):e72913. 2. Begtrup KM, Krag AE

2018 Swedish Council on Technology Assessement

2. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Full Text available with Trip Pro

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Researchers have suggested that omega-3 polyunsaturated fatty acids from oily fish (long-chain omega-3 (LCn3), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), as well as from plants (alpha-linolenic acid (ALA)) benefit cardiovascular health. Guidelines recommend increasing omega-3-rich foods, and sometimes supplementation, but recent trials have not confirmed this.To assess effects (...) of increased intake of fish- and plant-based omega-3 for all-cause mortality, cardiovascular (CVD) events, adiposity and lipids.We searched CENTRAL, MEDLINE and Embase to April 2017, plus ClinicalTrials.gov and World Health Organization International Clinical Trials Registry to September 2016, with no language restrictions. We handsearched systematic review references and bibliographies and contacted authors.We included randomised controlled trials (RCTs) that lasted at least 12 months and compared

2018 Cochrane

3. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Full Text available with Trip Pro

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Researchers have suggested that omega-3 polyunsaturated fatty acids from oily fish (long-chain omega-3 (LCn3), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), as well as from plants (alpha-linolenic acid (ALA)) benefit cardiovascular health. Guidelines recommend increasing omega-3-rich foods, and sometimes supplementation, but recent trials have not confirmed this.To assess effects (...) of increased intake of fish- and plant-based omega-3 for all-cause mortality, cardiovascular (CVD) events, adiposity and lipids.We searched CENTRAL, MEDLINE and Embase to April 2017, plus ClinicalTrials.gov and World Health Organization International Clinical Trials Registry to September 2016, with no language restrictions. We handsearched systematic review references and bibliographies and contacted authors.We included randomised controlled trials (RCTs) that lasted at least 12 months and compared

2018 Cochrane

4. Omega-3 fatty acid addition during pregnancy. Full Text available with Trip Pro

Omega-3 fatty acid addition during pregnancy. Higher intakes of foods containing omega-3 long-chain polyunsaturated fatty acids (LCPUFA), such as fish, during pregnancy have been associated with longer gestations and improved perinatal outcomes. This is an update of a review that was first published in 2006.To assess the effects of omega-3 LCPUFA, as supplements or as dietary additions, during pregnancy on maternal, perinatal, and neonatal outcomes and longer-term outcomes for mother (...) and child.For this update, we searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (16 August 2018), and reference lists of retrieved studies.Randomised controlled trials (RCTs) comparing omega-3 fatty acids (as supplements or as foods, stand-alone interventions, or with a co-intervention) during pregnancy with placebo or no omega-3, and studies or study arms directly comparing omega-3 LCPUFA doses or types. Trials

2018 Cochrane

5. Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease. Full Text available with Trip Pro

Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease. Maintaining long-term vascular access patency is necessary for high quality haemodialysis (HD) treatment of patients with the terminal and most serious stage of chronic kidney disease (CKD) - end-stage kidney disease (ESKD). Oral supplementation with omega-3 fatty acids (ω-3FA) may help to prevent blockage of the vascular access by reducing the risk of thrombosis and stenosis.To evaluate (...) , and ClinicalTrials.gov.Randomised controlled trials (RCTs) of omega-3 fatty acids versus placebo that assessed the patency of arteriovenous fistula (AVF) or arteriovenous graft (AVG) types of vascular access in ESKD patients.We assessed the risk of bias of each eligible study using the Cochrane Risk of Bias tool and made separate overall risk of bias judgments for the efficacy and safety outcomes. The certainty of evidence was assessed using the GRADE approach. The primary efficacy outcome was loss of vascular patency

2018 Cochrane

6. Is there evidence to support the use of omega-3 fatty acids in preventing cardiovascular events?

Is there evidence to support the use of omega-3 fatty acids in preventing cardiovascular events? Is there evidence to support the use of omega-3 fatty acids in preventing cardiovascular events? – Clinical Correlations Search Is there evidence to support the use of omega-3 fatty acids in preventing cardiovascular events? October 17, 2019 8 min read By Lily Cao Peer Reviewed A quick web search would suggest countless reasons to take fish oil, a supplement that Americans have fallen in love (...) with. In 2012, fish oil, which is composed of two omega-3 fatty acids–eicosapentaenoic acid (EPA) and docasahexaenoic acid (DHA)—was the natural product . 1 The potential health benefit of fish oil was first postulated in the 1970s by Danish scientists visiting an Inuit village in Greenland. The scientists discovered that the villagers, who ate a diet rich in omega-3 fatty acids, had lower levels of cholesterol and triglycerides compared to the Danish population. Early scientific studies went on to further

2019 Clinical Correlations

7. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association Full Text available with Trip Pro

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search December 2019 November 2019 October 2019 September 2019 August 2019 July 2019 June 2019 May 2019 April 2019 March 2019 February 2019 January 2019 This site uses (...) cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association , PhD , MD, FAHA, Chair , PhD, FAHA , MD, FAHA , PhD, RD, FAHA , PhD , MD, FAHA , PhD, RN, FAHA , MD, FAHA , MD, MPH, FAHA , MD, FAHA , MD, PhD , MD, MPH, FAHA , MD, PhD, FAHA Ann C. Skulas-Ray , Peter W.F. Wilson , William S. Harris , Eliot

2019 American Heart Association

8. Is there evidence to support the use of omega-3 fatty acids in preventing cardiovascular events?

Is there evidence to support the use of omega-3 fatty acids in preventing cardiovascular events? Is There Evidence to Support the Use of Omega-3 Fatty Acids in Preventing Cardiovascular Events? – Clinical Correlations Search Is There Evidence to Support the Use of Omega-3 Fatty Acids in Preventing Cardiovascular Events? May 24, 2019 8 min read By Lily Cao Peer Reviewed A quick web search would suggest countless reasons to take fish oil, a supplement that Americans have fallen in love (...) with. In 2012, fish oil, which is composed of two omega-3 fatty acids–eicosapentaenoic acid (EPA) and docasahexaenoic acid (DHA)—was the natural product most commonly used by US adults, with nearly 20 million Americans taking the supplement. 1 The potential health benefit of fish oil was first postulated in the 1970s by Danish scientists visiting an Inuit village in Greenland. The scientists discovered that the villagers, who ate a diet rich in omega-3 fatty acids, had lower levels of cholesterol

2019 Clinical Correlations

9. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. Full Text available with Trip Pro

Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. To assess effects of increasing omega-3, omega-6, and total polyunsaturated fatty acids (PUFA) on diabetes diagnosis and glucose metabolism.Systematic review and meta-analyses.Medline, Embase, Cochrane CENTRAL, WHO International Clinical Trials Registry Platform, Clinicaltrials.gov, and trials in relevant (...) systematic reviews.Randomised controlled trials of at least 24 weeks' duration assessing effects of increasing α-linolenic acid, long chain omega-3, omega-6, or total PUFA, which collected data on diabetes diagnoses, fasting glucose or insulin, glycated haemoglobin (HbA1c), and/or homoeostatic model assessment for insulin resistance (HOMA-IR).Statistical analysis included random effects meta-analyses using relative risk and mean difference, and sensitivity analyses. Funnel plots were examined

2019 BMJ

10. Omega-3 fatty acids during pregnancy and asthma prevention. Are we talking here about more than just a suspect involved?

Omega-3 fatty acids during pregnancy and asthma prevention. Are we talking here about more than just a suspect involved? Ácidos grasos omega-3 durante el embarazo y prevención del asma, ¿algo más que un presunto implicado? - Evidencias en pediatría Buscando, por favor espere. Mostrar menú Gestión de biblioteca Aún no ha añadido ningún artículo a su biblioteca. | Buscar Toma de decisiones clínicas basadas en pruebas científicas Toma de decisiones clínicas basadas en pruebas científicas Mostrar (...) menú Gestión de biblioteca Aún no ha añadido ningún artículo a su biblioteca. × Usuario Contraseña Entrar × Restablecer contraseña Si desea restablecer su contraseña, por favor indique a continuación su email, pulse el botón Enviar y se le enviará un correo para poder completar el proceso. Email Enviar × Gestión de biblioteca × Junio 2017. Volumen 13. Número 2 Ácidos grasos omega-3 durante el embarazo y prevención del asma, ¿algo más que un presunto implicado? Valoración: 0 (0 Votos) Revisores

2017 Evidencias en Pediatría

11. Omega-3 Supplements for Dry Eye: Fishy evidence or a big catch?

Omega-3 Supplements for Dry Eye: Fishy evidence or a big catch? Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca (...) September 10, 2018 Omega-3 Supplements for Dry Eye: Fishy evidence or a big catch? Clinical Question: Does oral omega-3 supplementation improve symptoms of dry eye disease? Bottom Line: The evidence for omega-3 is inconsistent. The best quality randomized control trial (RCT) found that omega-3 supplementation does not improve dry eye symptoms or function. Smaller RCTs suggest statistically significant benefits in symptom scores that are not always clinically relevant. At best, omega-3 will improve

2018 Tools for Practice

12. Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis. (Abstract)

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis. Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) are necessary for optimum mental health, with recent studies showing low n-3 LCPUFA in people at ultra-high risk (UHR) of developing psychosis. Furthermore, people at UHR of psychosis had increased erythrocyte sphingomyelin (...) (SM) and reduced phosphatidylethanolamine (PE) concentrations as well as 27 erythrocyte phospholipid species that differed when compared to erythrocytes from age matched people not at UHR of psychosis. The aim of this analysis was to evaluate the effect of n-3 supplementation on the different erythrocyte lipid species (including SM and PE concentrations) in people at UHR of psychosis. Participants were randomly assigned to fish oil (containing 840 mg EPA and 560 mg DHA per day) or placebo

2019 Schizophrenia Research

13. Association of 3-Year Multidomain Intervention and Omega-3 Supplementation with Frailty Incidence (Abstract)

Association of 3-Year Multidomain Intervention and Omega-3 Supplementation with Frailty Incidence To assess the associations of long-term lifestyle multidomain intervention (MI) and omega-3 supplementation with frailty level evolution and frailty incidence in community-dwelling older persons.Secondary analysis of the randomized controlled Multidomain Alzheimer Preventive Trial.Thirteen memory centers in France and Monaco between 2008 and 2011.A total of 1588 community-dwelling persons aged 70 (...) years or older with memory complaints (without dementia), slow gait speed, or limitation in one instrumental activity of daily living.A 3-year MI (43 group sessions including cognitive training, physical activity, and nutrition advice and three preventive consultations) plus daily omega-3 fatty acids, MI plus placebo, omega-3 alone, or placebo alone.The frailty phenotype (unintentional weight loss, exhaustion, low physical activity, slow gait, low handgrip strength: 0 to 5 score, higher is worse

2019 EvidenceUpdates

14. Omega-3 fatty acid supplements

Omega-3 fatty acid supplements Omega-3 fatty acid supplements | Advice | NICE Omega-3 fatty acid supplements Key therapeutic topic [KTT4] Published date: January 2015 Advice The key therapeutic topic omega-3 fatty acid supplements has been incorporated into the key therapeutic topic lipid-modifying drugs . See for more information. Explore © NICE [year]. All rights reserved. Subject to .

2015 National Institute for Health and Clinical Excellence - Advice

15. Omega-3 and polyunsaturated fat for prevention of depression and anxiety symptoms: systematic review and meta-analysis of randomised trials

Omega-3 and polyunsaturated fat for prevention of depression and anxiety symptoms: systematic review and meta-analysis of randomised trials Omega-3 and Polyunsaturated Fat for Prevention of Depression and Anxiety Symptoms: Systematic Review and Meta-Analysis of Randomised Trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other (...) characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Br J Psychiatry Actions , 1-8 2019 Oct 24 [Online ahead of print] Omega-3 and Polyunsaturated Fat for Prevention of Depression and Anxiety Symptoms: Systematic Review and Meta-Analysis of Randomised Trials , , , , , , , Affiliations Expand Affiliations 1 Senior Lecturer

2020 EvidenceUpdates

16. The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression. Full Text available with Trip Pro

The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression. Depression is a leading cause of disease burden and disability for older adults; thus, prevention is a priority. Biologic and observational data support potential mental health benefits of vitamin D and omega-3 fatty acids; however, it is unclear whether (...) these supplements can prevent late-life depression.We describe the novel methodology of a large-scale study: VITAL-DEP (VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention), an ancillary to the VITAL trial. Primary Aims of VITAL-DEP are to determine effects on prevention of depression and on trajectory of mood symptoms of long-term (mean=5years) supplementation with vitamin D (vitamin D3 [cholecalciferol], 2000IU/day) and marine omega-3 fatty-acids (eicosapentaenoic acid + docosahexaenoic acid, 1g/day

2018 Contemporary clinical trials Controlled trial quality: uncertain

17. Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index. (Abstract)

Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index. To investigate the changes in specific domains of cognitive function in older adults reporting subjective memory complaints with a low omega-3 index receiving omega 3 polyunsaturated fatty acid (n-3 PUFA) supplementation or placebo.This is a secondary exploratory analysis of the Multidomain Alzheimer Preventive Trial (MAPT) using subjects randomized to the n-3 PUFA supplementation (...) or placebo group.French community dwellers aged 70 or over reporting subjective memory complaints, but free from clinical dementia.A subgroup of MAPT subjects in the lowest quartile of omega-3 index distribution with baseline values ≤ 4.83 % (n = 183).The n-3 PUFA supplementation group consumed a daily dose of DHA (800 mg) and EPA (a maximum amount of 225 mg) for 3 years. The placebo group received identical capsules comprising liquid paraffin oil.Linear mixed-model repeated-measures analyses were used

2018 The journal of nutrition, health & aging Controlled trial quality: predicted high

18. Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN) Full Text available with Trip Pro

Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN) This randomized controlled trial investigated the safety and efficacy of MF4637, a high concentrate omega-3 fatty acid preparation, in correcting the omega-3 fatty acid nutritional deficiency in non-alcoholic fatty liver disease (NAFLD). The primary end point of the study was set as the change of red blood cell (RBC) eicosapentaenoic acid (EPA (...) ) and docosahexaenoic acid (DHA) by MF4637. Whether the omega-3 concentrate could lower liver fat was evaluated in a subset of patients. Furthermore, 176 subjects with NAFLD were randomized to receive the omega-3 concentrate (n = 87) or placebo (n = 89) for 24 weeks, in addition to following standard-of-care dietary guidelines. The omega-3 index, omega-6: omega-3 fatty acid ratio and quantitative measurements of RBC EPA and DHA were determined at baseline and study completion. Magnetic resonance imaging of liver

2018 Nutrients Controlled trial quality: uncertain

19. Modulation of the endogenous omega-3 fatty acid and oxylipin profile in vivo-A comparison of the fat-1 transgenic mouse with C57BL/6 wildtype mice on an omega-3 fatty acid enriched diet. Full Text available with Trip Pro

Modulation of the endogenous omega-3 fatty acid and oxylipin profile in vivo-A comparison of the fat-1 transgenic mouse with C57BL/6 wildtype mice on an omega-3 fatty acid enriched diet. Dietary intervention and genetic fat-1 mice are two models for the investigation of effects associated with omega-3 polyunsaturated fatty acids (n3-PUFA). In order to assess their power to modulate the fatty acid and oxylipin pattern, we thoroughly compared fat-1 and wild-type C57BL/6 mice on a sunflower oil

2017 PLoS ONE

20. Randomised controlled trial: Possible protective effect of prenatal omega-3 long-chain polyunsaturated fatty acids supplementation on persistent wheeze and asthma in early childhood

Randomised controlled trial: Possible protective effect of prenatal omega-3 long-chain polyunsaturated fatty acids supplementation on persistent wheeze and asthma in early childhood Possible protective effect of prenatal omega-3 long-chain polyunsaturated fatty acids supplementation on persistent wheeze and asthma in early childhood | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your (...) browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Possible protective effect of prenatal omega-3 long-chain

2017 Evidence-Based Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>